OMNI-EGFR
Live / Allowed — Third extension granted (statement of use) (as of 28 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jan 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98358756
- Mark type
- Word mark
- Filed
- 16 Jan 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Julia Spoor Gard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
Owner
- BlossomHill Therapeutics, Inc., San Diego, CA, US
- BlossomHill Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 29 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2026 — SOU EXTENSION 3 GRANTED
- 28 Jul 2026 — SOU EXTENSION 3 FILED
- 28 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — SOU EXTENSION 2 GRANTED
- 26 Jan 2026 — SOU EXTENSION 2 FILED
- 26 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2025 — SOU EXTENSION 1 GRANTED
- 22 Aug 2025 — SOU EXTENSION 1 FILED
- 22 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION